Birds at two Bernard Matthews breeder sites in Suffolk and Norfolk have tested positive for avian influenza, though not the highly pathogenic H5 or H7 types.
A movement restriction has been put in place by DEFRA, but a cull has not so far been required. The BBC has the full story at: http://news.bbc.co.uk/1/hi/england/7912529.stm
Vetoquinol is advising vets and farmers to be on the lookout following the discovery of counterfeit Marbocyl on two farms in Northern Ireland.
The counterfeit product contains an unapproved source of Marbofloxacin in an untested formulation which presents an unknown risk to animal and human health if used.
Vetoquinol has informed the national authorities about this situation. It is illegal either to sell or supply the product or to knowingly buy and/or use it.
The withdrawal period of this counterfeit product is unknown. Should the product be used it could be detected in milk or after slaughter. Vetoquinol advises the veterinary community to be aware of the risk, to carefully check the product packaging before use and to continue to source the product from reputable suppliers.
Vetoquinol urges vets and farmers to take the following actions if you find this product on farm or are approached to purchase it:
Vetoquinol says vets can rest assured that it will do all that is necessary to remove this product from the market.
If you need further information or advice, do not hesitate to contact Vetoquinol on 0800 1698197.
VRCC the Essex-based veterinary referral specialists and centre for the treatment of cancer in dogs and cats has become the first in the UK to offer a canine melanoma vaccine.
The vaccine, previously only available in the U.S. where it has been granted a conditional license by the USDA, has been made available to VRCC's Head of Oncology Dr Susan North who fulfils the US Academic Credentials required.
According to VRCC, most oral tumours are not noticed early by owners, so many go undiagnosed and untreated until they are advanced and the dog has a poor chance of recovery.
Canine melanoma is an aggressive neoplasm treated with surgery and/or radiation therapy, which readily metastasises to the lymph nodes, liver, lungs and kidneys but is chemo-resistant. There is little evidence that chemotherapy improves survival time.
The canine melanoma vaccine develops effective immunotherapy in dogs that recognises and targets specific antigens on melanoma cells and may account for long-term tumour control and survival.
The vaccine is indicated for dogs with stage II or stage III oral melanoma for which local disease control has been achieved: negative local lymph nodes or positive lymph nodes that were surgically removed or irradiated.
The conditional license was granted based on the reasonable expectation that when used along with surgery and/or radiation therapy to treat the initial tumour the vaccine may help extend survival time and improve quality of life in dogs with canine oral melanoma.
US research concluded that canine patients with advanced disease have a median survival time of less than 5 months with standard therapies. In initial trials, dogs receiving the vaccination sequence had a median survival time of 389 days.
A canine transdermal device is especially matched to the vaccine for needle-free delivery and optimal distribution. Veterinary surgeons with a patient with oral melanoma should contact Dr Susan North at VRCC, www.vrcc.co.uk to discuss the case at an early stage, as initial treatment is important to ensure suitability for the vaccine.
The RCVS issued a reminder today that there is just over a month left before the 1 April deadline for all veterinary practice premises from which medicines are to be supplied to be registered with the College.
Just over 4,500 premises have applied for registration since November 2008. This includes about 750 premises not previously listed with the College, demonstrating the usefulness of the process, which will enable the government to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines.
From 1 April it will be an offence for a veterinary surgeon to supply a veterinary medicinal product from any practice premises not registered with the RCVS. On conviction, those committing the offence may be liable to prosecution, which may include a fine or prison sentence. Veterinary surgeons convicted of criminal offences are also considered by the College's Preliminary Investigation Committee to decide whether the conviction would affect the individual's fitness to practise and should be referred to the Disciplinary Committee.
In addition to ensuring their practice premises are registered, veterinary surgeons also need to keep a record of other places where medicines are stored, so these can be considered during an inspection - such as vets' homes or cars, or perhaps a charity premises from which veterinary work is carried out and where medicines are stored. Such records will not be published, although some of those premises may need to be registered in their own right.
Practices accredited under the RCVS Practice Standards Scheme will be inspected by the RCVS; non-compliance with medicines standards will be dealt with under the rules of the Scheme. The Veterinary Medicines Directorate (VMD) will carry out inspections of other registered premises to ensure compliance with the Veterinary Medicines Regulations. Where non-compliance is noted, the VMD will take a proportionate enforcement approach ranging from issuing advice to, where appropriate, serving an improvement notice or seizing medicines.
The British Veterinary Dental Association (BVDA) has signed a new agreement with Hill's Pet Nutrition which will provide support for the next three years.
The agreement comes after the previous period of sponsorship between the company and the BVDA reached the end of the three year term.
Lisa Milella, President, signed the agreement on behalf of the BVDA. She said: "Hill's has provided our organisation with invaluable support that will help us to continue to support the teaching needs of vets, undergraduates and nurses. We will also be able to ensure that dentistry is front of mind when thinking about the health and welfare of animals. Hill's has been a pleasure to work with over the last three years and I am very pleased to be renewing our agreement."
Adrian Pratt, Veterinary Affairs Manager at Hill's Pet Nutrition also welcomed the agreement, "Dentistry is an important source of revenue for practices and central to the wellbeing of pets. Both are priority areas where Hill's will be offering support, particularly during the current economic downturn. We are therefore very pleased to be able to confirm our association with the BVDA."
The agreement comes as the BVDA prepares to celebrate its 21st Birthday at BSAVA Congress in April. The satellite day event on the 1st April promises to be a 'must' for anyone interested in veterinary dentistry, with state of the art lectures that will illustrate how far the craft of dentistry has developed in the last 21 years.
The key note lecture, 'Magical MTA!*' will be delivered by Phil Thomson, Registrar at Birmingham Dental School, using a video linked operating microscope to illustrate how this gold standard endodontic treatment can be implemented. Additional lectures include oro-facial tumours, reconstructive surgery, radiotherapy and an active debate is promised on the topic of feline chronic gingivostomatitis. The meeting is open to members and non-members. Further details and registration are available by contacting Lisa Milella on telephone 01923 349690 or at lisa@milella.fsnet.co.uk.
*Mineral Trioxide Aggregate - MTA - a root canal repair material that allows natural healing and repair of dental tissues of otherwise unsalvageable teeth.
Janssen Animal Health is encouraging vets and nurses to think 'chicken' this spring.
According to the company, all the evidence suggests that there has been a massive increase in the number of people keeping a few chickens in their garden, resulting in a new breed of chicken owner who often has different expectations regarding healthcare, and views their birds as 'pets'.
Vet Nigel Underwood from Janssen Animal Health said: "It is very tempting for small animal practitioners to think that domestic poultry keepers are the preserve of large animal practices but it is very likely that many cat and dog owners will own chickens too and trust their vet to give them advice about the basic healthcare needs of all their pets."
This spring there is a big opportunity to make poultry owners aware of the need to worm their birds. The return of warmer weather can signal an increase in poultry worm numbers as the ambient temperature increases above 10 degrees centigrade and more worm eggs become infectious. Studies have shown that peak worm counts often coincide with peak chicken egg production. Unless chickens, turkeys and geese are de-wormed there is a risk that egg production could suffer, just when poultry keepers should be enjoying their best yields. Some may even notice smaller eggs and loss of shell and yolk colour. Birds may suffer weight loss, become anaemic or even die.
One study has shown that older birds are more likely to harbour worms and many domestic poultry keepers find themselves with an ageing flock because they allow their birds to live a full natural lifespan. Free range birds are also much more at risk of picking up parasitic worms because of increased exposure to the outdoors, more contact with wild birds and the opportunities to ingest intermediate hosts such as earthworms, beetles and snails.
Janssen Animal Health's Flubenvet® 60 gram pack is an in-feed treatment that, according to the company, is practical even for those with just a few hens in their garden. Flubenvet 60 gram contains enough wormer to treat around 20 chickens, with no egg withdrawal.
While worms are a year-round problem in poultry it is especially important to treat in the spring to tackle the increasing threat of worm infection. Thereafter, poultry owners will also get the best results if they continue to treat regularly in spring, summer and autumn, when new birds are acquired and before putting birds out to pasture. This helps to ensure that contamination of the chickens' environment with worm eggs is kept at a manageable level, reducing the risk of future infections.
Free client leaflets about worms affecting chickens, geese and turkeys are available by calling Janssen Animal Health on 01494 567555.
Janssen Animal Health has launched a range of skincare products - Cavalesse® and Cavalesse® Topical - to help maintain and support a healthy skin in horses prone to summer skin allergies.
According to the company, summer skin allergies, including sweet itch, which is caused by reactions to bites from Culicoides midges, can be serious and frustrating conditions that affect three to five per cent of all horses in the UK. These allergies can be difficult to manage and are often a real challenge for both horse owners and vets alike.
Cavalesse is a natural food supplement containing a specialised formulation of water-soluble vitamins and minerals, including Nicotinamide. Once a month the contents of each sachet are dissolved in water to form an oral solution, which can be administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat such as a sugar lump. The supplement helps horses maintain a healthy skin by reducing histamine release within the skin, moderating the excessive immune response within the skin, reducing anti-inflammatory reactions and suppressing antigen induced transformation.
To complete the Cavalesse skin management range, Cavalesse Topical is a skincare gel that can be used in combination with the Cavalesse solution. The gel can be applied to the skin to help support natural immunity from the outside, whilst the oral solution works in partnership from the inside.
Helen Goldberg, marketing manager at Janssen Animal Health said: "Summer skin allergies, such as sweet itch, are frustrating conditions that can be difficult to treat. To help prevent the disease, horses are often fully blanketed while out at grass, given limited access to pasture or covered with insect repellents, while treatment has included antihistamines and corticosteroids which can have side-effects.
"Only available via veterinary wholesalers, the Cavalesse range of products will enable owners to protect their horses from the inside, whilst maintaining a healthy skin from the outside."
2ml of Cavalesse should be administered to horses and ponies weighing less than 500kg daily, while horses weighing more than 500kg should be given 3ml per day. Cavalesse Topical should be applied to the skin according to requirements.
For further information, please contact your Janssen Animal Health account manager or phone 01494 567555.
According to the results of DairyCheck 2008, Intervet/Schering-Plough Animal Health's subsidised milk testing service, 65% of herds tested positive for IBR infection, 69% positive for Leptospirosis and the majority of herds tested showed evidence of previous BVD exposure.
According to Intervet/Schering Plough, it is widely known that exposure levels of these three endemic diseases are high, yet many producers don't see the hidden losses. Making use of DairyCheck can demonstrate infection levels on an individual unit and help encourage a control and management programme to be put in place
Vet adviser Ruth Vernon said: "It can be a case of 'out of sight, out of mind'. After the initial infection, cows may appear healthy, but be suffering from the effects of immune suppression as a result of BVD virus infection. This results in herd performance that is often below expected levels."
"When the news is good - and on average around 33% of DairyCheck tested herds were found to be clear of all three diseases - farmers need guidance and advice on keeping a naïve herd clear of disease.
"Taking time to explain how to incorporate biosecurity measures on a day-to-day basis as well as quarantine and vaccination programmes can significantly improve the health status of previously infected units."
Further information on DairyCheck is available from Intervet/Schering-Plough Account Managers.
A new long acting sheep injection has been launched by Fort Dodge Animal Health which the company says will offer significant benefits to sheep farmers for both internal and external parasite control.
Cydectin 2% LA for sheep is the latest product to join the Cydectin range and follows the long acting injection for cattle.
Based on Moxidectin, the product delivers a long action against worms, up to 111 days and scab, 60 days from a single injection.
Andrew Wylie from Fort Dodge said: "To put this into context, apart from the existing Cydectin range which lasts up to 35 days, no other product is licensed with persistent activity against worms and scab. Cydectin 2% LA for sheep offers three times the worm cover and double the scab cover from a single injection.
"Therefore farmers will benefit from Cydectin 2% LA through the combination of a single injection with extended persistency leading to a reduction in the number of treatments needed for worms and scab and the potential increase in lamb weight gain due to a lower worm and scab challenge."
Fort Dodge recommends the following three key uses for Cydectin 2% LA given the persistent effect and single shot:
Administration is by a single sub-cutaneous injection high up the neck at the base of the ear which is designed to limit the withhold period to 104 days. The technique is not difficult and, if used with the multidose applicator supplied, farmers will find it a straightforward procedure.
Cydectin 2% LA is available in 50ml, 200ml and 500ml bottles and with a dose rate of 1ml per 20kg, a 500ml pack will treat 200 sheep at 50kg. For further, call Fort Dodge on 01489 781711.
Genitrix has announced that HY-50 Vet®, a sodium hyaluronate treatment for equine joints, has now been authorised for intravenous (IV) use.
Available until now for intra-articular (IA) use only, the company says HY-50 delivers the highest concentration of sodium hyaluronate on the market for the treatment of non-infectious joint inflammation and the enhancement of joint function.
Genitrix also says that, as IV application requires less specialist preparation than IA, HY-50 is now a practical solution for mixed practices with a smaller equine case load. Injected intravenously, the product will also benefit horses with multiple joint injuries.
HY-50 is presented in a 3 ml pre-loaded syringe, delivering 50 mg of sodium hyaluronate. It costs £55.50.
Rob Watkins, Marketing Director of Genitrix, said: "The efficacy of sodium hyaluronate is well established and we're delighted to be able to offer the IV route of administration. We know it will meet a real need in the market for a lameness treatment which is proven and simple to administer."
"Perhaps most importantly, in these financially difficult times, the high concentration of the product makes it a cost-effective approach compared with competitive products. We believe it will offer an affordable treatment option for owners who are anxious to treat their horses but may be discouraged by the high cost of many treatments."
For further information, see http://www.genitrix.co.uk/ or ring 01403 786345.
The RCVS and the Veterinary Medicines Directorate (VMD) will be holding a free Masterclass offering practical guidance on the requirements of the Veterinary Practice Premises Register, on Saturday 4 April, at BSAVA Congress.
If you are concerned about medicines inspections and would like further information about complying, this is your chance to find out what you need to do.
By 1 April, all practice premises from which medicines are supplied should be registered with the RCVS. All such premises are then subject to inspection - by either Practice Standards Scheme inspectors, if accredited under the Scheme, or VMD inspectors. Will you be ready if an inspector calls?
Suitable for veterinary surgeons, veterinary nurses and practice managers, the interactive session will be held from 10am - 12noon, with presentations from VMD and the Chief Inspector of the Practice Standards Scheme, followed by group discussion and plenty of time for questions and answers.
Attendance at the Masterclass, which will be held in Hall 6 of the ICC in Birmingham, is free to BSAVA passholders.
For your free ticket, contact Fiona Harcourt on 020 7202 0773, f.harcourt@rcvs.org.uk, or during Congress visit the RCVS Stand, number 918, opposite the catering stand in the Exhibition hall.
Bayer has introduced a new microchip scanner which is capable of reading all chips, including encrypted ones.
The company says the new Tracer Advance Isomax V scanner offers exceptional reading distances of more than twice those of other scanners on the market, making it a very versatile tool ideally suited for use in companion animal practices or for detecting microchips in larger animals such as horses.
The technology that gives this scanner its backward compatibility with non ISO standard chips means practices can now save money by only having to buy one scanner, whereas previously two were required to be able to read all types of chip.
Other features of the device include digital signal processing (DSP), which protects against radio interference from TVs and PCs, and connectivity via USB, RS232 or optional Bluetooth interface.
The Tracer Advance Isomax V scanner is available from Bayer and is priced at £499.95. It comes with a 30-month warranty. Contact your Bayer territory representative for further details.
Dairy vets will soon be receiving a DVD highlighting the economic losses due to coccidiosis in cattle, from Janssen Animal Health.
According to the company, coccidiosis is a major cause of scouring and poor growth rates in calves yet recent findings have demonstrated that a massive 61 per cent of the economic loss occurs in sub-clinically infected calves that are not showing any obvious clinical signs. Treated calves have been shown to put on 20 per cent more weight than untreated calves1. Coccidiosis infects between 16 and 27 per cent of adult cattle who act as reservoirs of the disease2,3,4,5. This means that most calves are likely to become exposed to the infectious form of the parasite. After the age of 6 months the majority of calves acquire immunity but if they are exposed to a massive challenge before that time due to large numbers of the coccidial oocysts or due to a stress factor, sub-clinical or clinical disease occurs.
The DVD describes the challenges involved in diagnosing coccidiosis and how to interpret faecal oocyst counts, as well as some of the characteristics of sub-clinical infection in calves. The benefits of metaphylactic and preventative approaches to treatment with Vecoxan®, the only anticoccidial drench licensed for beef and dairy cattle at any age, indoors and out, are discussed.
Nigel Underwood from Janssen Animal Health said: "The diagnosis of non-specific scour is problematic at best but it is important that vets have coccidiosis at front of mind when considering the differential diagnosis. Prompt treatment of the whole batch of calves can stop the disease in its tracks and does not interfere with the development of future immunity. We hope this DVD will provide an update on the latest thinking and help increase recognition of this disease."
The DVD will be sent out in February and any vet with an interest in the disease who does not received one before the end of the month should call Janssen on 01494 567555 to request a copy.
Further information is available from Janssen Animal Health, 50-100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG Tel 01494 567555 Fax 01494 567556 Email: ahealth@jacgb.jnj.com
References
Woodley Equipment Co Ltd has announced that it has been appointed by Synermed International as the exclusive distributor in the UK & Europe for the IR202 Series Near-Infrared Biochemistry reagents.
Woodley will supply regular maintenance visits, support and a monthly supply of reagents to IR202 analyser customers.
For further information, visit www.woodleyequipment.com, www.synermedinc.com, email sales@woodleyequipment.com or telephone 01798 813659.
The 2009 RCVS Continuing Professional Development Record Cards have been sent to all practising vets and Registered Veterinary Nurses.
Undertaking and recording Continuous Professional Development (CPD) is a mandatory professional requirement for these vets and RVNs. Vets must average at least 35 hours of CPD per year and RVNs 15 hours, although many will do far more.
The RCVS can ask to see CPD records - and they may be checked during practice inspections as part of the Practice Standards Scheme. For newly-qualified veterinary surgeons, completing the Professional Development Phase also fulfils the CPD requirements in their first year of practice.
Jill Nute, President of the RCVS, said: "CPD is about maintaining professional competence. Vets and RVNs are expected to make continuous improvements in their knowledge and skills, which will have benefits for their patients and clients, their own development and the profession at large. Undertaking CPD allows vets and RVNs to demonstrate their commitment to maintaining the highest professional standards."
As professionals, vets and RVNs are expected to evaluate what knowledge and skills they need to develop, and how they will do this. This may include activities such as going to particular case-conferences or asking for some in-house training. Getting together with other practices to organise training sessions or secondments or finding a mentor can also be useful.
Personal study - documented in a learning diary detailing the aims of the study, what was studied and the outcomes, for example, a change made to a practice protocol - can also be used. There is no limit on properly documented study, but vets cannot count more than 10 hours, and veterinary nurses five hours, each year of undocumented study.
All CPD activity should be systematically planned to meet identified professional needs, and clear records must be kept of what has been done.
Further information about CPD requirements for veterinary surgeons and Registered Veterinary Nurses can be found on the back of the CPD Record Card, and at RCVSonline (www.rcvs.org.uk).
The Disciplinary Committee of the Royal College of Veterinary Surgeons last week ordered a month's suspension for a veterinary surgeon from Dolgellau for dishonest certification of bovine tuberculin testing in the Gwynedd area in early 2007.
At a hearing that concluded last Friday, Iwan Parry, a partner of The Veterinary Surgery, Bala Road, Dolgellau, and an Official Veterinarian, was charged with serious professional misconduct for certifying on eight separate occasions that he had tested and inspected cattle for clinical signs of bovine tuberculosis (TB), when he had not done so. At the outset of the hearing, Mr Parry denied the charges.
The Committee heard that Animal Health (a DEFRA Executive Agency) had discovered irregularities in TB testing paperwork from Mr Parry's practice. These included two locum veterinary surgeons, who were not Local Veterinary Inspectors (LVIs), having carried out TB pre-movement testing, but the relevant paperwork being signed and certified by Mr Parry. It therefore suspended him from LVI duties and lodged a complaint with the RCVS.
The Committee heard that, at the time, Mr Parry's practice was in difficulty as all eight of his assistant veterinary surgeons had recently left and he was struggling to maintain services. It was also reported that the incidence of bovine TB in Mr Parry's area was very low.
Under questioning, Mr Parry admitted that he had not done the testing, but had allowed non-LVI veterinary surgeons to do so and then signed the certificates himself. Denying the charge of dishonesty, he maintained that he had thought his actions were legitimate, providing he questioned the veterinary surgeons afterwards and checked their results. However, he told the Committee he now deeply regretted this "honest mistake", made at a time of great personal pressure, and that it would not be repeated.
The Committee also heard evidence from a number of character witnesses, including Mr Elfyn Llwyd MP, testifying to Mr Parry's good character, integrity and good standing in the local community and agricultural sector.
Nevertheless, in view of Mr Parry's long experience as an LVI, his understanding of the importance of routine herd testing and accurate veterinary certification and his reputation for keeping up to date with legislative and professional developments, the Committee decided that his actions were not just inappropriate, but were the result of conscious impropriety on his part. It found that he was not only guilty of dishonesty, but of allowing non-LVIs to perform TB testing, both of which amounted to serious professional misconduct.
In passing judgment, the Committee emphasised that the integrity of veterinary certification was of the utmost importance, especially when carried out on behalf of the Government, in order to safeguard animal health and facilitate international trade. It also felt that Mr Parry could not have failed to have been fully aware of what he was signing and that he should not have done so.
It was, however, prepared to take account of some exceptional mitigating factors in this case, including the low risk of TB spread following Mr Parry's actions; that no financial gain had been sought or received by him; his unblemished career and uprightness of conduct to date; the esteem in which he was held in the farming community and the potential (financial) impact on that community if he were to be removed from the Register (therefore unable to practise) for a significant period of time.
Nigel Swayne MRCVS, chairing the Disciplinary Committee, concluded: "We are reminded that the primary purpose of any sanction is not punishment, but the maintenance of public confidence in the profession and to uphold professional standards of conduct.
"Whilst only a reprimand is not an appropriate sanction where dishonesty and false certification have been found proved, and such findings would normally attract at least a long period of suspension, given the wholly exceptional circumstances of this case and the strength of the mitigating factors, we direct that Mr Parry should be suspended for one month."
VetSurgeon members Ian and Gillian Mostyn, and the team at Pennine Vets are doing the Coniston Challenge later this year: 30kms of arduous cycling, hiking and canoeing for Guide Dogs.
You can support them with a donation, however small (£2 minimum) at: http://www.justgiving.com/penninevetschallenge.
Bayer Animal Health has signed a deal to sponsor GMTV's pet clinic to promote its market-leading wormer, Drontal.
Running from Monday 16 February to Friday 20 February, the pet clinic will feature TV vet Emma Milne advising viewers on the health and welfare of their pets.
The pet clinic slots will run twice a day throughout the week on GMTV and Drontal will be featured in the end credits. The advertising will target the product's core target audience - housewives with children - with key messages on the importance of regular worming with Drontal. In addition, GMTV will also include details on Drontal on its website - www.gm.tv, where pet owners will be able to follow a link to www.drontal.com.
Dan White, Drontal's product manager said: "By sponsoring GMTV's pet clinic, Bayer is highlighting the benefits of worming and encouraging pet owners to regularly worm their pets. The advertising features the iconic schnauzer (the face of Drontal's "Worms? Absolutely Not!'' campaign) and will serve to drive clients into practices asking for Drontal. This will not only result in healthier dogs and cats but also ultimately reduce the environmental reservoir of eggs."
CEVA Animal Health has launched Diarsanyl Plus, a new intestinal support paste for dogs, cats and small animals containing prebiotics.
Diarsanyl Plus contains the same unique combination of ingredients as Diarsanyl - montmorillonite, Na+, Mg2+ and K+ ions and dextrose - but now also contains prebiotics called fructo-oligosaccharides (FOS).
According to the company, montmorillonite maintains intestinal function by coating and protecting the enterocytes and absorbing toxins, Na+, Mg2+ and K+ ions help maintain electrolyte levels and dextrose provides a much needed energy source for the small intestine. The prebiotics help maintain normal intestinal flora by promoting the growth of good bacteria such as bifidobacteria and lactobacilli and stimulating the production of short chain fatty acids (SCFAs) - acetate, propionate and butyrate - which are important energy sources for the large intestine.
Fraser Broadfoot, product manager at CEVA Animal Health said: "Diarsanyl Plus will build on the proven efficacy of Diarsanyl by including prebiotics that naturally balance the intestinal flora of animals with digestive upsets and diarrhoea. The new easy-to-use syringes and palatable formulation will also make it easier for pet owners to administer."
Diarsanyl Plus is available in 10ml, 24ml and 60ml pack sizes for a variety of species, from small animals to large dogs.
For further information, please contact your CEVA Animal Health representative or call 01494 781510.
Understanding profit and loss within a veterinary practice is vital for all employees. That was the message delivered to delegates attending Pippa Reffold's lecture, sponsored by Dechra Veterinary Products, at the VPMA Congress late last month.
Pippa said: "Very few practice managers set targets or share financial data with their employees. Employees have a lot to contribute by improving service and increasing sales."
Roger Brown, product manager at Dechra Veterinary Products said: "Sponsoring Pippa's lecture is part of Dechra Veterinary Products response to market conditions. We have also reduced the price of two key products in our Veterinary Essentials range.
"We realise how significant margin control is right now and constantly review our Veterinary Essentials range. That's why we have reduced prices on Atipam 5ml, the Thyroxyl range and have introduced the Essentials Purchase Plan so practices can make further savings.
Pippa added: "Be open-minded about margin setting and don't apply a blanket mark-up to all products. Consider the contribution to your gross profit and passing on some of the improvement to your customers."
Dechra Veterinary Products offers a margin and profit calculator to compare market prices with the Veterinary Essentials range - to show just how much mark-up can be applied to products without impacting on a client's budget. "It's a simple, but very effective calculation that our Territory Managers can run for you," explained Mr Brown.
To find out more about the Veterinary Essentials range, including further cost savings with an Essentials Purchase Plan and free margin development advice, please call Liz Rawlings on 01743 441632.
40% of Brits are more likely to trust their vet's advice above that of other health practitioners such as GPs, dentists and opticians, according to research announced today by Petplan.
The younger generation are the least trusting in their human healthcare providers with a resounding majority of those surveyed in the 16 to 24 age group saying they are most likely to trust their vet's advice over their doctor's.
Nationally, nearly four out of ten pet owners put more faith in vets than doctors, rising to 7 in 10 in some parts of the country.
Talking of which, my mother needs a new hip. Any of you up for it?
Intervet/Schering-Plough Animal Health has produced a new Orf Vaccination Starter Pack to help vets better inform their sheep farmer clients about the disease.
The new campaign Vaccination Starter Pack includes a practical guide to Orf and its control in UK sheep flocks, a DVD profiling vet and farmer experiences of managing the disease, an 'Orf questions answered' handout and a best practice vaccination protocol. Additional practice support materials highlighting the problems caused by Orf and its control with Scabivax Forte are also available.
The Starter Pack and full range of promotional materials are available from local Intervet/Schering-Plough Account Managers or by contacting the Veterinary Support Group on 01908 685685.
A special interest group has been established for vets, veterinary nurses and chartered physiotherapists interested in the rehabilitation of diseased and injured animals. 'Physiovet UK' aims to provide practical training in the field of veterinary rehabilitation and pain management.
The group's inaugural CPD meeting takes place on Wednesday 20th May this year in Cardiff and will be led by specialist in small animal surgery (orthopedics) Steve Butterworth and veterinary rehabilitation specialist Lowri Davies. Sponsored by Hill's Pet Nutrition and Merial Animal Health, the meeting will cost £80 for members or £100 for non-members (ex VAT) for the day long event. Membership of the group costs £50.
Lowri Davies, a founder member of Physiovet said: "At this first meeting, the focus is on helping to develop a protocol for diagnosis and management strategies for conditions of the hock, shoulder and lumbosacral cases. Practitioners will recognise that these are commonly occurring conditions that are often managed conservatively but treatment need not stop with a prescription of 'rest'. We will be describing a range of active interventions that build strength, flexibility and general fitness appropriate to lame animals to help restore function and mobility."
For a downloadable registration form for the event, to join as a member or for further information about the group visit http://www.physiovet.co.uk/. Places at the meeting can also be booked by calling 01626 867614 or by contacting kathrin@linhayvet.co.uk.
Vetoquinol has announced the launch of Rubenal®, a new product for use in renal health management for dogs and cats.
Normal kidney function is dependent upon normal nephron and interstitial tissue structure. When the balance of renal health is tipped, this structure can change and fibrous tissue can accumulate.
Simon Boulton, Rubenal®'s product manager said: "Rubenal® is the first palatable veterinary formulation of Rheum officinale available for use in both dogs and cats. It can be used as an aid to the maintenance of the normal renal fibrotic architecture."
The company has also produced a new guide to the management of chronic renal failure in dogs and cats: Chronic Kidney Disease: Addressing quality of life and life expectancy.
Simon said: "Vetoquinol is dedicated to supporting renal health and the guide is designed to illustrate factors which can affect both quality and quantity of life, including hyperphosphataemia, hypertension, proteinuria, azotaemia and fibrosis in renal disease."
The booklet contains guidelines on the appropriate management of these factors including a wall chart reference guide.
For more information about Rubenal, or a free copy of the guide, please contact your Vetoquinol representative or telephone 0800 1698197.
Intervet/Schering-Plough Animal Health has announced the replacement of its Bovilis® IBR with Bovilis® IBR Marker Live vaccine, a move that brings the UK into line with the rest of Europe where marker vaccines are favoured.
Many EU member states, including Scandinavia and Austria are now declared IBR-free, and others (Germany and Hungary) operate national eradication programmes. Using a marker vaccine will help farmers wishing to export animals, or semen, or those working towards an eradication programme in their herds.
Recent bulk milk and blood screening via Intervet/Schering-Plough's complimentary BeefCheck and DairyCheck has revealed that 72% of herds tested were positive for IBR exposure. Given the latent nature of infection, and the rumbling losses associated with subclinical disease, it should come as no surprise that farmers are increasingly interested in controlling IBR. Studies have shown that IBR infection can result in a milk yield reduction of 173 litres per infected animal, or over £400 a year, for a 100-cow herd.
According to Intervet/Schering-Plough, Bovilis IBR Marker Live is Europe's leading IBR vaccine. It can be given intra-muscularly or intra-nasally to calves as young as two weeks old, as well as pregnant dams. It is also licensed to be given together with the pneumonia vaccine Bovilis® Bovipast RSP. The primary course involves one dose in cattle over three months of age, with immunity in just four days from the intra-nasal method, and 14 days from injection. Stock need re-vaccination every six months.
The vaccine reduces the amount of virus excreted into the environment, so minimising the risk to stressed cattle which may have been brought into the herd, and be latently infected. It also makes it an excellent choice for producers with breeding bulls, which should not be vaccinated. Bulls have to be kept naïve, however, the marker vaccine can be used on females in the herd to minimise virus circulation. This way the threat is minimised, and bulls can be kept infection free.